HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaohong Chen Selected Research

Matrix Metalloproteinase 9 (Gelatinase B)

1/2019Poly(lactic-co-glycolic acid) nanoparticle-mediated interleukin-12 delivery for the treatment of diabetic retinopathy.
8/2013Minocycline reduces oxygen-glucose deprivation-induced PC12 cell cytotoxicity via matrix metalloproteinase-9, integrin β1 and phosphorylated Akt modulation.
5/2013The protective effect of berberine against neuronal damage by inhibiting matrix metalloproteinase-9 and laminin degradation in experimental autoimmune encephalomyelitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaohong Chen Research Topics

Disease

55Neoplasms (Cancer)
01/2022 - 11/2002
14Inflammation (Inflammations)
01/2022 - 06/2008
14Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2021 - 05/2009
13Multiple Sclerosis
01/2021 - 05/2009
9Infections
01/2022 - 07/2008
8Pain (Aches)
11/2021 - 02/2007
8Squamous Cell Carcinoma of Head and Neck
12/2020 - 01/2010
7Neoplasm Metastasis (Metastasis)
12/2021 - 08/2011
7Carcinoma (Carcinomatosis)
12/2021 - 05/2013
7Alzheimer Disease (Alzheimer's Disease)
05/2020 - 08/2008
7Urinary Bladder Neoplasms (Bladder Cancer)
08/2016 - 01/2003
6Carcinogenesis
11/2018 - 03/2004
5Hepatocellular Carcinoma (Hepatoma)
02/2022 - 01/2002
5Melanoma (Melanoma, Malignant)
01/2022 - 10/2005
5Fibrosis (Cirrhosis)
05/2021 - 01/2002
5Breast Neoplasms (Breast Cancer)
02/2021 - 04/2013
5Thyroid Neoplasms (Thyroid Cancer)
01/2021 - 12/2013
4Gestational Diabetes (Gestational Diabetes Mellitus)
05/2022 - 01/2018
4Prostatic Neoplasms (Prostate Cancer)
01/2022 - 04/2008
4Laryngeal Neoplasms (Laryngeal Cancer)
08/2021 - 10/2015
4Colitis
03/2021 - 01/2019
4Rhinosinusitis
03/2021 - 01/2018
4Ischemic Stroke
01/2020 - 07/2011
4Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2019 - 02/2011
4Type 1 Diabetes Mellitus (Autoimmune Diabetes)
09/2018 - 05/2017
4Head and Neck Neoplasms (Head and Neck Cancer)
01/2016 - 06/2013
3Disease Progression
01/2022 - 09/2014
3Pulmonary Fibrosis (Fibrosing Alveolitis)
10/2021 - 09/2008
3Hypoalbuminemia
03/2021 - 11/2020
3Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 11/2018
3Anemia
11/2020 - 01/2020
3Lymphatic Metastasis
01/2020 - 05/2015
3Nasal Polyps (Nasal Polyp)
01/2020 - 01/2018
3Acute Kidney Injury (Acute Renal Failure)
01/2020 - 05/2015
3Diabetic Retinopathy (Retinopathy, Diabetic)
01/2019 - 06/2008
3Parkinson Disease (Parkinson's Disease)
01/2013 - 04/2011
3Cystitis
01/2011 - 01/2007
2Anti-N-Methyl-D-Aspartate Receptor Encephalitis
01/2022 - 01/2020
2Encephalitis (Encephalitis, Rasmussen)
01/2022 - 01/2020
2Hypertension (High Blood Pressure)
01/2022 - 11/2020
2COVID-19
01/2022 - 01/2021
2Stroke (Strokes)
01/2022 - 12/2017
2Hypotension (Low Blood Pressure)
12/2021 - 12/2021
2Paraganglioma (Paragangliomas)
10/2021 - 01/2019
2Margins of Excision
08/2021 - 02/2017
2Granuloma
08/2021 - 02/2021

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2002
11Pharmaceutical PreparationsIBA
04/2022 - 02/2011
9Biomarkers (Surrogate Marker)IBA
01/2022 - 07/2014
8CytokinesIBA
12/2021 - 01/2003
7MicroRNAs (MicroRNA)IBA
02/2022 - 09/2014
6Minocycline (Cyclops)FDA LinkGeneric
05/2015 - 05/2009
5Morphine (MS Contin)FDA LinkGeneric
11/2021 - 10/2008
5CreatinineIBA
01/2021 - 01/2020
5Biological ProductsIBA
05/2020 - 01/2012
4Uric Acid (Urate)IBA
01/2022 - 01/2013
4Chemokine ReceptorsIBA
11/2021 - 12/2018
4Analgesics (Analgesic Drugs)IBA
11/2021 - 01/2017
4Opioid Analgesics (Opioids)IBA
11/2021 - 12/2018
4Formaldehyde (Formol)FDA Link
11/2021 - 05/2009
4InterleukinsIBA
03/2021 - 03/2004
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2021 - 03/2004
4Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 04/2011
4HomocysteineIBA
05/2020 - 04/2011
4EnzymesIBA
11/2018 - 12/2004
3AcidsIBA
02/2022 - 01/2016
3Messenger RNA (mRNA)IBA
01/2022 - 09/2010
3LipidsIBA
05/2021 - 07/2014
3Ethanol (Ethyl Alcohol)IBA
03/2021 - 01/2020
3Dextran SulfateIBA
03/2021 - 07/2020
3VaccinesIBA
01/2021 - 11/2002
3CateninsIBA
01/2021 - 12/2013
3Amino AcidsFDA Link
01/2021 - 11/2018
3Interleukin-23 (Interleukin 23)IBA
01/2021 - 12/2014
3Glucose (Dextrose)FDA LinkGeneric
01/2021 - 08/2013
3Neuroprotective AgentsIBA
12/2020 - 07/2011
3ChemokinesIBA
01/2020 - 12/2018
3Interleukin-12 (IL 12)IBA
01/2019 - 03/2004
3Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2019 - 05/2013
3Folic Acid (Vitamin M)FDA LinkGeneric
10/2018 - 12/2016
3Brain-Derived Neurotrophic Factor (BDNF)IBA
05/2015 - 09/2010
3Nerve Growth Factor (NGF)IBA
07/2012 - 06/2008
2Interleukin-2 (IL2)IBA
04/2022 - 03/2004
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2022 - 01/2020
2Fatty Acids (Saturated Fatty Acids)IBA
01/2022 - 05/2021
2Long Noncoding RNAIBA
01/2022 - 08/2014
2RNA (Ribonucleic Acid)IBA
01/2022 - 08/2014
2Immune Checkpoint InhibitorsIBA
01/2022 - 11/2021
2Penicillins (Penicillin)FDA Link
01/2022 - 01/2021
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
11/2021 - 01/2016
2LigandsIBA
05/2021 - 05/2018

Therapy/Procedure

27Therapeutics
11/2021 - 03/2004
11Renal Dialysis (Hemodialysis)
12/2021 - 01/2016
8Immunotherapy
01/2022 - 03/2004
7Radiotherapy
01/2022 - 10/2013
5Drug Therapy (Chemotherapy)
11/2021 - 05/2015
5Lasers (Laser)
08/2021 - 05/2013
4Operative Time
01/2019 - 12/2013
3Analgesia
11/2021 - 01/2019
2Anesthesia
08/2021 - 02/2021